Skip to main content

Use of Higher Dosage Strength Oral and Transmucosal Opioid Analgesics

Basic Details
Date Posted
Status
Complete
Medical Product
higher dosage strength opioid analgesic
lower dosage strength opioid analgesic
opioid analgesic
oral opioid analgesic
transdermal opioid analgesic
transmucosal opioid analgesic
Description

This analysis consists of two reports. Report 1 estimates background rates of higher dosage strength opioid analgesic users in the Sentinel Distributed Database (SDD). Report 2 calculates summary statistics on length of treatment episode among users of higher dosage strength opioid analgesics in the SDD. Data from January 1, 2012 to June 30, 2018 from 17 Data Partners contributing to the SDD were included in this request. This request was distributed to Data Partners on November 12, 2018.

Deliverables (2)
Sentinel Modular Program Report: Use of Higher Dosage Strength Oral and Transmucosal Opioid Analgesics, Report 1 Sentinel Modular Program Report: Use of Higher Dosage Strength Oral and Transmucosal Opioid Analgesics, Report 2
Additional Details
FDA Center
CDER
Time Period
January 1, 2012 - June 30, 2018
Analysis Type
Descriptive
Population / Cohort
All individuals
Data Sources
Sentinel Distributed Database (SDD)
Related Links
Sentinel Drug Study: Higher Dosage Strength Oral and Transmucosal Opioid Analgesic Products